US · Healthcare

Janux Therapeutics Inc (JANX)

Biotechnology

Janux Therapeutics Inc (JANX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for JANX

P/E ratio

18.00

Janux Therapeutics Inc (JANX) — FAQ

What is JANX's P/E ratio?

The price-to-earnings (P/E) ratio for Janux Therapeutics Inc (JANX) is 18.00 (data as of 2026-03-24).

Does Janux Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Janux Therapeutics Inc (JANX). Check the MyAverix Finance app for the latest dividend data.

What sector is Janux Therapeutics Inc in?

Janux Therapeutics Inc (JANX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is JANX listed on?

JANX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)